Fortress Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:FBIO.P Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
18 Aug 23	BuyUS$210,900	Lindsay Rosenwald	Individual		20,000	US$11.75

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 121.4%.

Top 25 shareholders own 49.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.4%	Lindsay Rosenwald	2,960,824	US$5.2m	16.2%	no data
7%	Michael Weiss	1,346,985	US$2.3m	19.2%	no data
3.97%	Heights Capital Management, Inc.	764,549	US$1.3m	0%	0.77%
3.16%	Rosalind Advisors, Inc.	607,797	US$1.1m	0%	0.98%
3.1%	Armistice Capital LLC	596,000	US$1.0m	0%	0.03%
2.11%	Altium Capital Management LP	405,122	US$704.9k	0%	0.4%
1.94%	Nantahala Capital Management, LLC	372,562	US$648.3k	-7.14%	0.06%
1.84%	The Vanguard Group, Inc.	353,893	US$615.8k	0.95%	no data
1.84%	DAK Capital Inc	353,399	US$614.9k	0%	no data
1.7%	Hudson Bay Capital Management LP	327,235	US$569.4k	0%	0.01%
1.16%	Shikiar Asset Management Inc.	223,136	US$388.3k	21.8%	0.12%
0.68%	PVG Asset Management Corp	131,490	US$228.8k	0%	1.1%
0.68%	Acadian Asset Management LLC	130,188	US$226.5k	81.6%	no data
0.6%	J. Lobell	115,692	US$201.3k	6.11%	no data
0.56%	Corient Private Wealth LLC	107,658	US$187.3k	7,980%	no data
0.49%	Perkins Capital Management, Inc.	93,767	US$163.2k	0%	0.15%
0.45%	B. Riley Wealth Advisors, Inc.	85,975	US$149.6k	791%	no data
0.39%	BlackRock, Inc.	74,939	US$130.4k	0%	no data
0.36%	Eric Rowinsky	68,797	US$119.7k	41%	no data
0.32%	Envestnet Asset Management, Inc.	62,362	US$108.5k	0%	no data
0.32%	Wilcoxson Wealth Management	61,717	US$107.4k	16.3%	no data
0.29%	Geode Capital Management, LLC	56,699	US$98.7k	-5.54%	no data
0.26%	Wealth Enhancement Advisory Services, LLC	50,936	US$88.6k	-46.3%	no data
0.26%	Paramount BioSciences, LLC	49,524	US$86.2k	0%	100.0%
0.23%	George Avgerinos	43,678	US$76.0k	0%	no data